SPECTRE Special Pathogens Excellence in Clinical Treatment Readiness & Education Program

Welcome to SPECTRE!

We are SPECTRE—the Special Pathogens Excellence in Clinical Treatment, Readiness, and Education Program—housed within the Division of Infectious Diseases at UTMB. Our mission is to strengthen local and regional readiness to respond to high-consequence infectious diseases, ensuring self-sufficiency and operational resilience.

SPECTRE supports the ongoing preparedness of UTMB’s Biocontainment Care Unit (BCU) by developing targeted training and education initiatives grounded in practical, frontline care. We focus on equipping healthcare professionals, across all of Region 6, with the skills, tools, and confidence needed to act swiftly and safely during special pathogen events.

We also foster collaboration with regional healthcare partners and public health entities, promoting a unified, state-driven response framework that ensures coordination without unnecessary duplication of federal efforts. In addition, we contribute to the infrastructure needed for clinically grounded research, ensuring that emerging knowledge translates directly into improved patient care and safety protocols.

 

Trending Topics

Who is SPECTRE

SPECTRE strengthens healthcare preparedness through training, education, research, and regional coordination. By equipping healthcare professionals with specialized skills, advancing infectious disease research, and leading regional preparedness efforts, SPECTRE enhances the ability to manage high-consequence infectious diseases. This video highlights SPECTRE’s mission and its role in providing healthcare professionals with the knowledge and resources needed to respond effectively. Through evidence-based education, research, and strategic partnerships, SPECTRE helps build stronger response capabilities at institutional, regional, and national levels.

What we do

News & Events

 Latest News

Locally Acquired Malaria Infections in Texas and Florida Prompts CDC Health Advisory

Texas and Florida have both identified local transmitted cases of malaria Plasmodium vivax strain. This is the first of such reports since 2003. Subsequently, the Center’s for Disease Control and Prevention (CDC) has advised clinicians to consider malaria for any patients presenting with fever of unknown origin, regardless of their travel history. Additionally, medical personnel with patients from these two sites of local malaria origin should adhere to any additional guidance from their state and local health departments.

In Florida, four cases were confirmed in Sarasota County and a single case identified in Manatee County. Per the CDC, those cases do not appear to have any connection to the single case in Texas, which was identified in Cameron County, located near Brownsville in the southernmost tip of the state. Active surveillance for additional cases is underway in both locations. This particular strain of malaria is carried by Anopheles mosquitos, which have historic range within the U.S. but have largely subsided since control measures were put in place in the 50s.

Although the CDC emphasizes that citizens are still at extremely low risk of contracting malaria, they encourage the public to remain vigilant about prevention methods (preventing mosquito bites as well as preventing mosquito breeding in general) to help avoid the spread of malaria and other mosquito-borne illnesses. Those traveling to areas where malaria is more common should consult with health professionals about preventive medications, they can take in advance to reduce the likelihood of infection.

Illness caused by P. vivax can be milder than other strains, especially P. falciparum or P. knowlesi, but still warrants prompt medical attention. The CDC emphasizes that suspect patients should seek medical evaluation and diagnosis within 24 hours of symptom onset. For most people infected, symptoms start approximately 10 days to a month after infection, but it can range from as little as a week to as long as a year. Symptoms include fatigue, fever, chills, headache, and myalgias (muscle aches and pains). Of more concern, P. vivax and P. ovale have the potential to stay dormant in the liver and, if left untreated, can result in chronic infection and further relapses for years.

For the full CDC Health Advisory visit: https://utmb.us/8zp

What you need to know:

  • Four cases of locally acquired malaria (P. vivax) in Florida and a single case in Texas have been confirmed.
  • With increased international travel forecast for this summer, there may be more imported malaria cases ahead.
  • Clinicians should suspect malaria for patients with fevers of unknown origin and consider having first-line treatment options readily available.

What you can do

For Public:

  • Prevent Mosquito Bites
    • Use insect repellent.
    • Wear loose-fitting, long-sleeved shirts and pants.
    • Proactively control mosquitos indoors and outdoors.
    • Take preventative measures when traveling internationally.

For Clinicians:

       Malaria Prevention, Diagnosis, and Treatment

       Mosquito-Borne Disease Prevention

References

Centers for Disease Control and Prevention. (2023, June 26). Locally Acquired Malaria Cases Identified in the United States. Retrieved from Emergency Preparedness and Response: https://emergency.cdc.gov/han/2023/han00494.asp

Florida Department of Health. (2023, June 26). The Florida Department of Health Issues Mosquito-Borne Viruses Advisory. Retrieved from The Florida Department of Health: https://www.floridahealth.gov/diseases-and-conditions/mosquito-borne-diseases/_documents/advisory-statewide-6-26-2023.pdf

Florida Department of Health. (23, May 26). DOH-Manatee Issues Mosquito-Borne Illness Advisory: Single Case of Malaria Identified and Treated. Retrieved from Florida Department of Health: https://www.floridahealth.gov/diseases-and-conditions/mosquito-borne-diseases/_documents/alert-manatee-5-26-2023.pdf

Rios, L. M., & Connelly, R. C. (2018, October). Featured Creatures: Common Malaria Mosquito. Retrieved from University of Florida: Entomology and Nematology Department: https://entnemdept.ufl.edu/creatures/aquatic/Anopheles_quadrimaculatus.htm

Nicole Cloutier is a Research Associate for the SPECTRE Program.

 Upcoming Events